Study of Rifampicin in Multiple System Atrophy

NCT01287221 · clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
100
Enrollment
OTHER
Sponsor class

Stopped DSMB recommended stopping the study after an interim analysis of the primary endpoint revealed that futility criteria were met.

Conditions

Interventions

Sponsor

Phillip Low

Collaborators